NextCure, Inc. - Common Stock — Bilan (NASDAQ:NXTC) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 306.64 M242.39 M184.16 M128.04 M80.86 M50.18 M Total du passif 12.92 M9 M16.63 M13.62 M15.39 M15.24 M Total des capitaux propres 293.72 M233.39 M167.53 M114.42 M65.47 M34.94 M Total du passif et des capitaux propres 306.64 M242.39 M184.16 M128.04 M80.86 M50.18 M Dette totale 1.81 M1.81 M———— Dette nette 1.81 M1.81 M————

Nouvelles

Lucid Capital Markets initie une couverture de NextCure avec un objectif de 25,00$

NextCure présentera les données du médicament anticancéreux SIM0505 lors de la réunion de l’ASCO

NextCure fait le point sur ses programmes ADC et annonce sa position de trésorerie

NextCure provides updates on ADC programs, reports cash position

NextCure secures $21.5 million in private placement to extend cash runway

NextCure raises $21.5 million in private placement to fund ADC programs

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

NextCure (NXTC) Q2 Loss Widens 71%

NextCure stock soars after positive data for bone disease treatment

Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)

Piper Sandler lowers NextCure stock price target to $15 after reverse split